Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas

Gynecologic Oncology

Volumn 62, Issue 1, 1996, Pages 82-88

  Alama, Angela ^a   Barbieri, Federica ^a   Favre, Anna ^b   Cagnoli, Monica ^a   Noviello, Elvira ^a   Pedullà, Franco ^b   Viale, Maurizio ^a   Foglia, Gianni ^b   Ragni, Nicola ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL;

ADULT; ANIMAL EXPERIMENT; ARTICLE; ASCITES CELL; CANCER CELL CULTURE; CASE REPORT; CELL GROWTH; CELL ISOLATION; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PRIORITY JOURNAL;

EID: 0030200810     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0194     Document Type: Article

References (19)

1. 1. Cannistra, S. A. Cancer of the ovary, N. Engl. J. Med. 329, 1550-1559 (1993).
2. 2. McGuire, W. P. Primary treatment of epithelial ovarian malignancies, Cancer (Suppl.) 71, 1541-1550 (1993).
3. 3. Kaye, S. B. Chemotherapy for ovarian cancer, Eur. J. Cancer 29A, 632-635 (1993).
4. 4. Godwin, A. K., Testa, J. R., and Hamilton, T. C. The biology of ovarian cancer development, Cancer (Suppl.) 71, 530-536 (1993).
5. 5. Lounis, H., Provencher, D., Godbout, C., Fink, D., Milot, M. J., and Mes-Masson, A. M. Primary cultures of normal and tumoral human ovarian epithelium: A powerful tool for basic molecular studies, Exp. Cell Res. 215, 303-309 (1994).
6. 6. Hill, B. T., Whelan, R. D. H., Gibby, E. M., Sheer, D., Hosking, L., Shellard, S. A., and Rupniak, H. T. Establishment and characterization of three new human ovarian carcinoma cell lines and initial evaluation of their potential in experimental chemotherapy studies, Int. J. Cancer 39, 219-225 (1987).
7. 7. Buick, R. N., Pullano, R., and Trent, J. M. Comparative properties of five human ovarian adenocarcinoma cell lines, Cancer Res. 45, 3668-3676 (1985).
8. 8. Langdom, S. P., Lawrie, S. S., Hay, F. G., Hawkes, M. M., McDonald, A., Hayward, I. P., Schol, D. J., Hilgers, J., Leonard, R. C., and Smyth, J. F. Characterization and properties of nine human ovarian adenocarcinoma cell lines, Cancer Res. 48, 6166-6172 (1988).
9. 9. Mobus, V., Gerharz, C. D., Press, U., Moll, R., Beck, T., Mellin, W., Pollow, K., Knapstein, P. G., and Kreienberg, R. Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines, Int. J. Cancer 52, 76-84 (1992).
10. 10. van den Berg-Bakker, C. A. M., Hagemeijer, A., Franken-Postma, E. M., Smit, V. T., Kuppen, P. J. K., van Ravenswaay Claasen, H. H., Cornelisse, C. J., and Schrier, P. I. Establishment and characterization of 7 ovarian carcinoma cell lines and one granulosa tumor cell line: Growth features and cytogenetics, Int. J. Cancer 53, 613-620 (1993).
11. 11. Giunta, M., Favre, A., Ramarli, D., and Grossi, C. E. A novel integrin involved in thymocite-thymic epithelial cell interactions, J. Exp. Med. 173, 1537-1548 (1991).
12. 12. Santini, D., Ceccarelli, C., Mazzoleni, G., Pasquinelli, G., Jasonni, V. M., and Martinelli, G. N. Demonstration of cytokeratin intermediate filaments in oocytes of the developing and adult human ovary, Histochemistry 99, 311-319 (1993).
13. 1 integrin in normal and pathologic squamous epithelia, J. Invest. Dermatol. 102, 247-252 (1994).
14. 14. Mills, G. B., May, C., McGill, M., Roifman, C. M., and Mellors, A. A putative new growth factor in ascitic fluid from ovarian cancer patients: Identification, characterization and mechanism of action, Cancer Res. 48, 1066-1071 (1993).
15. 15. Wilson, A. P., Fox, H., Scott, I. V., Lee, H., Dent, M., and Golding, P. R. A comparison of the growth promoting properties of ascitic fluids and peritoneal fluids from patients with ovarian tumours, Br. J. Cancer 63, 102-108 (1991).
16. 16. Erba, E., Vaghi, M., Pepe, S., Amato, G., Bistolfi, M., Ubezio, P., Mangioni, C., Landoni, F., and Morasca, L. DNA index of ovarian carcinomas from 56 patients: In vivo in vitro studies, Br. J. Cancer 52, 565-573 (1985).
17. 17. Erba, E., Ubezio, P., Pepe, S., Vaghi, M., Marsoni, S., Torri, W., Mangioni, C., Landoni, F., and D'Incalci, M. Flow cytometric analysis of DNA content in human ovarian cancers, Br. J. Cancer 60, 45-50 (1989).
18. 18. Mobus, V., Moll, R., Gerharz, C. D., Kieback, D. G., Weikel, W., Hoffmann, G., and Kreienberg, R. Establishment of new ovarian and colon carcinoma cell lines: Differentiation is only possible by cytokeratin analysis, Br. J. Cancer 69, 422-428 (1994).
19. 19. Gruppo Interregionale Cooperativo Oncologico Ginecologia Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer, Lancet 2, 353-359 (1987).